Thrombotic microangiopathy after allogeneic bone marrow transplantation: a pathologic abnormality associated with diverse clinical syndromes
Management of CMV infections: recommendations from the infectious diseases working party of the EBMT
Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells
Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: a single-center comparative analysis of genoidentical, haploidentical or unrelated donors
Pre-transplant prognostic factors for patients with high-risk leukemia undergoing an unrelated cord blood transplantation
High-dose melphalan and autotransplantation followed by post transplant maintenance chemotherapy for acute lymphoblastic leukemia in first remission
Addition of ATG to the conditioning regimen is a major determinant for outcome after transplantation with partially lymphocyte-depleted grafts from voluntary unrelated donors
Cyclosporine and mycophenolate mofetil prophylaxis with fludarabine and melphalan conditioning for unrelated donor transplantation: a prospective study of 22 patients with hematologic malignancies
Second autologous transplant with cyclosporin/interferon α-induced graft versus host disease for patients who have failed first-line consolidation
Murine B-cell leukemia lymphoma (BCL1) cells as a target for NK cell-mediated immunotherapy
Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease
Encephalopathy in pediatric patients after allogeneic hematopoietic stem cell transplantation is associated with a poor prognosis
Mediastinal emphysema and bilateral pneumothoraces with chronic GVHD in patients after allogeneic stem cell transplantation
Stem Cells Handbook
Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells